Emerging Company Profile: IGEM Therapeutics has been spun out of King’s College London to evaluate the use of IgE-based monoclonal antibodies for the treatment of cancer, including difficult-to-reach solid tumors….
…..
See the article in full here: https://scrip.pharmaintelligence.informa.com/SC123214/IGEM-Therapeutics-Pursuing-Novel-IgE-Antibodies-For-Solid-Tumors